PRETORIA, Gauteng — The Council for Medical Schemes has officially declined the GEMS medical aid contribution increase application, dealing a significant blow to millions of public sector workers. Dr. Stan Moloabi, the Principal Officer of the Government Employees Medical Aid Scheme, confirmed that the regulator rejected their proposal to cap the annual adjustment at 7.5% starting July 1, despite the scheme providing all requested financial documentation.
For nurses, teachers, and police officers, healthcare premiums represent a massive portion of their monthly take-home pay. The regulator’s refusal to approve a more modest premium hike has ignited frustration among trade unions and scheme members, who are now demanding clarity on the financial maneuvering of the state-owned health fund. Because the sector operates under the strict guidelines of the Medical Schemes Act, any modifications to member benefits or monthly deductions require formal regulatory approval.
Regulatory Roadblocks: Trends vs. Projections
Following GEMS’s initial submission, the Council for Medical Schemes requested supplementary data on June 11 to make a final determination. After reviewing the additional files, the regulatory body outlined two primary roadblocks.
The first major point of contention revolved around how premium adjustments are calculated. GEMS argued that while their 2025 claims exceeded the budget, they had implemented new cost-saving measures to offset the difference. However, the regulator maintained that approvals must be grounded in historical claiming trends rather than a scheme’s projected future savings, regardless of the internal interventions planned.
The Solvency Dilemma
The second, and perhaps more critical, hurdle was the scheme’s financial solvency. GEMS recently reported a reserve ratio of 24.72%, slipping beneath the statutory 25% minimum. The Council expressed concern that enforcing the requested 7.5% contribution adjustment would further drain the fund, potentially pushing the solvency ratio down to a precarious 21% or 22%.
Addressing these solvency fears, Dr. Moloabi firmly denied that the scheme was attempting to circumvent legal financial requirements. He clarified that the Medical Schemes Act actually contains mechanisms for when a fund’s reserves dip below the quarter-mark. In such scenarios, the scheme is not breaking the law but is instead required to shift to quarterly reporting and submit a formal business and recovery strategy to prove its path back to financial health.
The “Snowball Effect” of the Pandemic
Explaining how the reserves dwindled, Dr. Moloabi pointed to the lingering economic aftermath of the global pandemic. During lockdown periods, hospital visits plummeted, causing medical aid reserves across the board to swell. In consultation with stakeholders through the PSBC, GEMS passed these savings onto members by enforcing minimal premium hikes—just 2% in one cycle and 5% in the next.
However, Dr. Moloabi noted that artificially suppressing premiums creates a compounding “snowball effect.” As the world reopened, patient claims didn’t just return to pre-pandemic levels; they surged past them. This combination of suppressed income and skyrocketing utilization ultimately dragged the reserve ratio below the legal threshold.
Massive Daily Payouts and Future Interventions
The financial scale of the scheme is immense. GEMS currently services over 2.3 million beneficiaries, disbursing roughly R180 million in claims every single day. Furthermore, the utilization rates within the public sector scheme significantly outpace those of many private competitors.
To stabilize the fund and curb these high utilization rates, GEMS is rolling out a series of aggressive structural changes. Dr. Moloabi highlighted a recent redesign of their “Tanzanite One” option, which was previously deemed excessively generous compared to industry standards and prone to benefit “buying down.”
Additionally, the scheme is deploying advanced managed care protocols and overhauling its approach to detecting fraud, waste, and abuse. These anti-fraud strategies have been specifically recalibrated to align with the findings of the recent Section 59 inquiry. Looking toward the 2027 benefit design, GEMS is also re-evaluating its underwriting criteria and beneficiary definitions to ensure long-term sustainability and achieve the necessary financial savings.